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THE SIALON II PROJECT 
IN BRIGHTON & HOVE
WORKING 
TOGETHER WITH 
GAY BUSINESSES  
TO TACKLE HIV 
Working collaboratively 
with gay businesses in 
delivering outreach for 
Men Who Have Sex with 
Men (MSM) is crucial in 
order to maximise the 
potential opportunities  
to reach those whom 
might not otherwise 
engage in HIV prevention 
and/or health promotion 
interventions or services 
across Europe.  However, 
the extent to which 
non-governmental 
organisations (NGOs) 
engage successfully 
with gay businesses to 
implement outreach 
and prevention activities 
for MSM differs greatly; 
despite evidence pointing 
to the potential of gay 
venues for public health 
and health promotion 
interventions[1] [2] 
In the UK context, the 
Terrence Higgins Trust 
(THT) in Brighton and 
nationally, has embraced 
collaborative working 
with gay venues as part 
of its ongoing outreach 
programmes for gay and 
other MSM.  Moreover,  
THT has participated 
actively in a number of 
European public health 
and research initiatives 
which have engaged a 
wide range of different gay 
business types  
in prevention  
and other health 
promotion activities,  
such as the Sunflower 
Project, the Everywhere 
Project  
(www.everywhereproject.
eu), the Everywhere  
in Japan project  
(Daiwa Foundation),  
and more recently,  
the SIALON II  
project  
(www.sialon.eu).
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THE SIALON II 
PROJECT
Led in the UK by  
Dr Nigel Sherriff from 
the Centre for Health 
Research at the University 
of Brighton, SIALON II  
has been running in 
Brighton since 2011 and is 
due to finish in early 2015. 
Coordinated in Europe by 
Dr Massimo Mirandola of 
the Regional Coordination 
Centre for European 
Project Management 
(CReMPE) in Verona, Italy, 
SIALON is a multi-partner 
cross-sectional survey 
engaging over 6,000 
MSM in 13 European 
cities including Barcelona 
(Spain), Bratislava 
(Slovakia), Brighton 
(UK), Brussels (Belgium), 
Bucharest (Romania), 
Hamburg (Germany), 
Lisbon (Portugal), Ljubljana 
(Slovenia), Sofia (Bulgaria), 
Stockholm (Sweden), 
Verona (Italy), Vilnius 
(Lithuania), and Warsaw 
(Poland).
In partnership with the 
WHO, UNAIDS, and local 
partner organisations 
including THT South, 
SIALON II aims to 
conduct a large-scale 
bio-behavioural survey 
among MSM in Europe 
in line with a Second 
Generation Surveillance 
System (SGSS) approach 
(see box 1), as well as 
implement meaningful 
and targeted prevention 
activities.  Although 
SIALON II is primarily 
a research project, it is 
also a capacity building 
project focusing on the 
development of individual 
capacity (e.g. skills and 
knowledge regarding 
alternative methods of 
testing, virology, research 
methodologies) and 
organisational capacity 
(e.g. SIALON outreach 
and prevention activities 
linking specifically  
to local NGO agendas).
SIALON II  
PROJECT OBJECTIVES
 To implement a  
bio-behavioural  
survey using Time-
Location Sampling  
(TLS) and Respondent-
Driven Sampling  
(RDS); 
 To estimate HIV 
prevalence (using oral 
fluid) among MSM 
though TLS in nine 
European countries 
(Belgium, Bulgaria, 
Germany, Poland, 
Portugal, Slovenia, 
Spain, Sweden, UK); 
 To estimate HIV, 
Syphilis, HBV, HVC 
prevalence among 
MSM through RDS 
in four European 
countries (Italy, 
Lithuania, Romania,  
and Slovakia);
 Identify, describe and 
analyse sexual risk 
behaviour patterns, 
prevention needs 
and sexual health in 
the MSM population 
through a survey 
modelling the 
relationship between 
risk behaviour,  
socio-ecological  
or contextual factors 
and biological  
samples;
 Pilot the testing 
algorithm for a 
syphilis rapid test in 
the MSM population 
in the context of a 
surveillance system. 
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The full methodological 
details of the entire 
SIALON II project will 
shortly be available  
on the project website  
(www.sailon.eu) as well  
as in peer reviewed 
journals.  The full and 
detailed results of the 
study are expected to  
be available in summer  
2015 once they have  
been approved formally 
by the WHO and the 
European Commission.  
Once the embargo has 
been lifted, findings 
relating to Brighton 
will be presented in this 
newsletter including 
estimated HIV prevalence 
as well as sexual risk 
behaviour patterns, 
substance (mis)use,  
sexual health indicators, 
and access to prevention 
programmes and testing.  
Data relating to other 
European cities will,  
where possible, also  
be presented. 
SIALON II  
IN BRIGHTON
The SIALON II project 
received ethical approval 
for the technical 
components of the study 
from the WHO Research 
Project Review Panel (RP2) 
in 2012, followed by full 
approval in 2013 by the 
Research Ethics Review 
Committee (WHO ERC). 
Ethical approvals were  
also received from the 
relevant institutional 
review board in each 
participating city; for 
Brighton, approval was 
received from the Faculty 
of Health and Social 
Sciences’ Ethics and 
Governance Committee 
(FREGC). 
SIALON II activities were 
conducted in Brighton in 
three phases as follows:
PHASE 1  
(2011-2012): 
FORMATIVE 
RESEARCH
Preliminary formative 
research was conducted 
in all participating cities, 
and in Brighton with the 
cooperation of THT.  This 
aspect of the research 
used questionnaires 
designed by the Robert 
Koch Institute in Berlin in 
order to explore in detail, 
the local context of the 
respective study sites.  This 
included examining areas 
such as previous research 
using Time-Location 
Sampling or Respondent-
Driven Sampling, data on 
gay-friendly commercial 
and non-commercial 
sites, HIV and STI 
testing opportunities, 
treatment guidelines, 
existing prevention and 
outreach activities and 
so on.  Findings from this 
formative research data 
were used in conjunction 
with access to secondary 
data from the European 
MSM Internet Survey 
(EMIS) [3].  Together, the 
results of this early phase 
were used to inform all 
aspects of the project 
design such as the SIALON 
II prevention campaign [4], 
the design of the study 
procedures and protocols 
(including sampling, 
questionnaire designed, 
and procedures), as well 
as starting the process of 
identifying and securing, 
the collaboration of local 
gay businesses. 
PHASE 2 (2013): 
BIOLOGICAL AND 
BEHAVIOURAL 
SAMPLE 
COLLECTION
In each SIALON II country, 
a sample size of n=400 
MSM per city was 
calculated. In Brighton, 
a total of 418 MSM 
matched biological and 
behavioural samples 
were collected using Time 
Location Sampling (TLS) 
via the collaboration of 
11 local gay venues.  Data 
collection took place over 
two months in April and 
May 2013.  For inclusion in 
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the study, MSM had  
to be present in one of the 
participating venues, have 
had any kind of sex (oral 
or anal, penetrative or not) 
at least once with another 
man in the previous 12 
months, be able to provide 
anonymous informed 
consent, agree to complete 
the study questionnaire, 
and agree to provide an 
oral fluid sample. 
Prior to the collection  
of an oral fluid sample,  
MSM were asked to 
complete a  
self-administered  
pen-and-paper 
behavioural questionnaire 
comprising of 36 items.  
This questionnaire was 
designed by the SIALON 
II network in line with 
the GARPR indicators 
(Global AIDS Response 
Progress Reporting) and 
piloted in each country 
prior to the main data 
collection.  On completion 
of the survey, MSM were 
asked to give an oral 
fluid sample which would 
later be tested for HIV.  
A unique identification 
number (barcode) was 
used in order to identify 
each questionnaire to 
link the behavioural 
information with the 
biological  data.  This 
approach was also used 
in order (i) to guarantee 
the privacy/anonymity of 
the participants and (ii) 
to minimise the potential 
for any mistakes in linking 
the different types of 
information.
As part of the data 
collection process, 
prevention activities 
were also conducted on 
the initial approach to 
participants.  Each MSM 
approached was offered 
a prevention pack and 
project information sheet.  
For those MSM who went 
on to participate, following 
the completion of the 
questionnaire and oral 
fluid sample, multiple-
choice ‘scratch’ cards  
were used by the  
data collector as a  
means of engagement  
and knowledge 
development.  In total 
for Brighton, over 1000 
SIALON II designed 
condom and lubricant 
packs were distributed, 
500 project information 
sheets, and a further 500 
prevention ‘scratch’ cards. 
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VIROLOGY
Oral fluid collection  
was accomplished  
using ORACOL devices 
(Malvern Medical 
Developments,  
Worcester, UK).   
Samples were sent to the 
laboratory no more than 
72 hours after collection.   
HIV-antibody testing  
on the oral fluid  
samples was performed 
according to the 
manufacturer’s  
instructions of GENSCREEN 
HIV 1/2 version 2,  
BIO-RAD. All HIV-reactive 
samples were re-tested 
with Vironostika  
HIV Ag/Ab, Biomerieux.   
In the case of an HIV-
reactive result in one or 
both tests, participants 
were encouraged during 
post-test counselling  
to be re-tested from blood 
via local care pathways.   
As a quality control, for 
each oral fluid sample, a 
total IgG antibodies ELISA 
test Human IgG ELISA 
Kit 1x96, Quantitative/
Immunology Consultants 
Laboratory was used in 
order to assess the sample 
suitability for testing.  
Before testing, each sample 
was diluted 1/250 by a 
recovery buffer.  Samples 
below 3.5 titre (cut-off) 
were excluded from the 
study as being invalid  
(see Figure 1).
COLLECTION  
OF RESULTS
7-10 days after data 
collection, participants 
were able to collect the 
results of their oral fluid 
test from THT using their 
unique barcode identifier. 
In the case test results were 
reactive, participants were 
encouraged to  
be re-tested on blood via 
local testing services as 
well as undertake a full 
sexual health screen. 
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Figure 1:  
Algorithm for oral fluid  
testing in TLS for surveillance purposes
ETA GENSCREEN
REACTIVE (OD>CUTOFF) NOT REACTIVE (OD<CUTOFF)
EIA VIRONOSTIKA TOTAL IgG QUANTITY
POSITIVE NEGATIVE IgG > 3.5 mg/L IgG < 3.5 mg/L
EXCLUDED FROM STUDY
NEGATIVE
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PHASE 3  
(2014-2015): 
STATISTICAL 
ANALYSIS AND 
REPORTING
At the time of writing 
(January, 2015),  
statistical analysis  
of the entire European 
data set for the SIALON II 
is well under way  
and is due to be 
completed by Spring 
2015.  As noted earlier, 
once completed, the 
findings have to be 
approved by the WHO  
and the European 
Commission before the 
embargo on presenting 
the data is lifted.  Whilst 
frustrating for all those 
involved in the study, 
such procedures are 
necessary to ensure the 
data and reporting are 
robust. 
The results of the HIV 
prevalence estimates  
for MSM using gay 
venues in Brighton as  
well as the behavioural 
data will be presented  
in this newsletter as  
soon as possible following 
approval.  Findings 
will also be reported in 
appropriate academic 
journals in due course,  
as well as in ‘highlight’ 
format for gay businesses 
and other local 
community organisations. 
FURTHER 
INFORMATION 
SIALON II is  
coordinated by the 
Regional Coordination 
Centre for European 
Project Management 
(CReMPE), Verona 
University Hospital, 
Veneto Region,  
Italy.  The SIALON II 
project is co-funded 
by the European 
Commission’s Public 
Health Programme  
2008-2013 (Grant 
Agreement No. 2010 
1211).  The contents  
of this document are the 
sole responsibility of the 
authors and can under 
no circumstances be 
regarded as reflecting the 
position of the European 
Commission or the 
SIALON II Project Steering 
Committee.
For the UK, contact:  
Dr Nigel Sherriff  
n.s.sherriff@brighton.
ac.uk
For Europe, contact: 
Dr Massimo Mirandola 
massimo.mirandola@
regione.veneto.it
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THT BRIGHTON LAUNCH  
HIV STIGMA STATEMENT
Politicians attending the 
event included Cllr Jason 
Kitcat, the Green Leader 
of Brighton & Hove 
Council, Cllr Geoffrey 
Theobald, the leader  
of the Conservative Group 
on the City Council, 
Cllr Graham Cox, the 
Conservative Prospective 
Candidate for Hove 
& Portslade and Katy 
Bourne, the Sussex Police 
& Crime Commissioner. 
Simon Kirby MP for 
Brighton Kemptown & 
Peacehaven was not able 
to attend but sent along  
a message of support.
In her speech, Dr 
Rosemary Gillespie the 
newly appointed Chief 
Executive of THT said that 
everything was on course 
to sustainably defeat 
HIV within a generation 
and reminded everyone 
that THT was formed 
by a group of friends 
of Terry Higgins, one of 
the first people to die 
of the illness in the UK, 
who were outraged that 
he had died alone and 
frightened because of 
STIGMA surrounding HIV/
Aids at the time by health 
professionals.
Three speakers from 
Positive Voices, told 
their poignant stories 
about how they had 
been affected by  
Stigma and how  
they had learnt to 
challenge it.
The meeting was hosted 
by THT’s Regional Manager 
Sue Peters and the 
presentation was delivered 
by THT’s Health Promotion 
Coordinator for Community 
Engagement and Outreach, 
Ross Boseley.
In the lead up to World Aids Day (WAD) on December 1, Terrence Higgins Trust (THT),  
the national sexual health charity launched a HIV STIGMA statement at their Brighton 
Office on Friday, November 28 in the presence of their Chief Executive, Dr Rosemary 
Gillespie, local politicians and health professionals.
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